Both optoacoustic and optical imaging are biophotonic imaging technologies. While optoacoustic imaging yields information about light absorption from both endogenous tissue chromophores and optical contrast agents, optical imaging only provides information from extrinsically administered agents by means of light emission (fluorescence or bioluminescence). In terms of performance, optical imaging can serve as an easy-to-use screening tool with limited resolution and depth penetration, while optoacoustic imaging can probe biological questions in more detail and at greater depth. In this iThera Medical-hosted webinar, included 10-minute presentations from three leading scientists who utilize both complementary imaging methods to study diseases on a molecular level, across three different applications:
- Cancer: Judith Weber PhD, University of Cambridge
- Inflammation: Alexa Hasenbach, University of Münster
- Diabetes: Dr Sheryl Roberts, Memorial Sloan Kettering
iThera Medical’s May 20, 2020 webinar streamed at 3:00 PM BST/ 4:00 PM CEST / 10:00 AM EDT.
EUPHORIA has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 830965. STARSTEM has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 761214. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.